IV Regular Insulin Dosing for Blood Glucose of 481 mg/dL
For a blood glucose of 481 mg/dL in a patient refusing subcutaneous insulin, start with a correction dose of 14-18 units of IV regular insulin based on insulin sensitivity, followed by continuous IV insulin infusion at 0.05-0.1 units/kg/hour if this represents diabetic ketoacidosis (DKA) or persistent severe hyperglycemia. 1
Initial Assessment and Approach
First, determine if this patient has DKA or hyperosmolar hyperglycemic state (HHS). Check for:
- Acidosis (venous pH, bicarbonate)
- Ketones (serum or urine)
- Mental status changes
- Volume status
If DKA is present: Start continuous IV insulin infusion at 0.05-0.1 units/kg/hour without an initial bolus (IV bolus insulin is not generally recommended for DKA) 2. The 2025 ADA guidelines recommend fixed-rate IV insulin infusion or nurse-driven protocols with variable rates based on glucose values 3.
If DKA is NOT present: Use the correction insulin scale for severe hyperglycemia.
Correction Dose for Non-DKA Hyperglycemia
For a blood glucose of 481 mg/dL (which falls in the ≥400 mg/dL category), the correction dose depends on insulin sensitivity 1:
- Insulin-sensitive patients (elderly, not eating, renal impairment): 14 units
- Usual patients: 16 units
- Insulin-resistant patients (on corticosteroids, previously required >80 units/day): 18 units
Start with the "usual" column (16 units) unless specific factors indicate otherwise 1.
Transition to Continuous Infusion
After the initial correction dose, if the patient requires ongoing IV insulin:
Calculate the continuous infusion rate at 0.05-0.1 units/kg/hour 2, 4. For most non-critically ill patients, target a blood glucose range of 140-180 mg/dL 3, 5, 6, 7.
For critically ill patients, the threshold for IV insulin initiation is 180 mg/dL, with a target range of 140-180 mg/dL 8, 6, 7. More aggressive targets (110-140 mg/dL) increase hypoglycemia risk without consistent benefit 7.
Critical Monitoring Requirements
- Hourly blood glucose monitoring initially, then every 2-4 hours once stable 3, 9
- Potassium levels every 2 hours - insulin drives potassium intracellularly and can cause dangerous hypokalemia 3, 2
- Do not give insulin if potassium <3.3 mEq/L; replete first 3
- Monitor for hypoglycemia, especially in patients with renal impairment (90% of hypoglycemia cases in one study had renal dysfunction) 10
Important Caveats
Avoid sliding scale insulin as monotherapy - this approach is strongly discouraged and associated with poor glycemic control 1, 5. The patient refusing subcutaneous insulin needs education about the superiority of scheduled basal-bolus regimens once stabilized.
Dextrose administration: Once blood glucose falls to 200-250 mg/dL (for HHS) or 150-200 mg/dL (for DKA), add dextrose-containing IV fluids while continuing insulin to prevent hypoglycemia and allow resolution of metabolic abnormalities 3, 9.
Renal function matters: Reduce initial insulin doses by 20-50% in patients with significant renal impairment (GFR <60 mL/min) or age ≥70 years 1.
The evidence strongly supports that prolonged use of correction insulin alone leads to inadequate glycemic control 1. Once the acute crisis resolves and the patient can eat, transition to a scheduled subcutaneous basal-bolus regimen is essential, even if this requires additional patient education and negotiation about the refusal of subcutaneous insulin 3, 5.